chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Arthralgia, Blood pressure measurement, Chills, Dizziness
Clinical narrative: lightheaded; stomach pain; feeling like fainting; that happened parallel to erratic high blood pressure 199/98.; nausea; Arm pain first day.; fatigue; palpitations; shakes; joints and muscle pain; joints and muscle pain; headache; Chills; night sweats; This is a spontaneous report from a contactable consumer. A 60-years-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 09Mar2021 10:30 (Batch/Lot Number: EN6199) as SINGLE DOSE (at the age of 60 years) for covid-19 immunisation .  Medical history included immune thrombocytopenia from an unknown date and unknown if ongoing , hypertension from an unknown date and unknown if ongoing , drug hypersensitivity from an unknown date and unknown if ongoing , covid-19 from Mar2020 to Sep2020, (COVID 19 Long-Hauler from Mar-Sep2020). Concomitant medications included amlodipine besilate, benazepril hydrochloride (AMLODIPINE BENAZEPRIL); simvastatin (SIMVASTATIN).  The patient previously took aspirin [acetylsalicylic acid] and experienced anaphylactic reaction, zantac and experienced rash and experienced peripheral swelling.  The patient experienced feeling like fainting (medically significant) on 13Mar2021 14:30 with outcome of recovering , that happened parallel to erratic high blood pressure 199/98 on 13Mar2021 14:30 with outcome of recovering , palpitations  on Mar2021 with outcome of recovering , lightheaded on 13Mar2021 14:30 with outcome of recovering , stomach pain on 13Mar2021 14:30 with outcome of recovering , shakes on Mar2021 with outcome of recovering , joints and muscle pain, headache on Mar2021 with outcome of recovering , chills on Mar2021 with outcome of recovering , night sweats on Mar2021 with outcome of recovering , nausea on 13Mar2021 14:30 with outcome of recovering , arm pain first day on 09Mar2021 with outcome of recovering , fatigue on Mar2021 with outcome of recovering.  The patient underwent lab tests and procedures which included blood pressure measurement: 120's-30's/70's, blood pressure measurement: 199/98   on 13Mar2021, platelet count: 99, sars-cov-2 test: Several negative tests on unspecified date.  The patient went to Urgent Care twice. The patient took no other vaccine in four weeks and the patient was not COVID tested post vaccination.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Hypertension, Myalgia, Nausea
Clinical narrative: lightheaded; stomach pain; feeling like fainting; that happened parallel to erratic high blood pressure 199/98.; nausea; Arm pain first day.; fatigue; palpitations; shakes; joints and muscle pain; joints and muscle pain; headache; Chills; night sweats; This is a spontaneous report from a contactable consumer. A 60-years-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 09Mar2021 10:30 (Batch/Lot Number: EN6199) as SINGLE DOSE (at the age of 60 years) for covid-19 immunisation .  Medical history included immune thrombocytopenia from an unknown date and unknown if ongoing , hypertension from an unknown date and unknown if ongoing , drug hypersensitivity from an unknown date and unknown if ongoing , covid-19 from Mar2020 to Sep2020, (COVID 19 Long-Hauler from Mar-Sep2020). Concomitant medications included amlodipine besilate, benazepril hydrochloride (AMLODIPINE BENAZEPRIL); simvastatin (SIMVASTATIN).  The patient previously took aspirin [acetylsalicylic acid] and experienced anaphylactic reaction, zantac and experienced rash and experienced peripheral swelling.  The patient experienced feeling like fainting (medically significant) on 13Mar2021 14:30 with outcome of recovering , that happened parallel to erratic high blood pressure 199/98 on 13Mar2021 14:30 with outcome of recovering , palpitations  on Mar2021 with outcome of recovering , lightheaded on 13Mar2021 14:30 with outcome of recovering , stomach pain on 13Mar2021 14:30 with outcome of recovering , shakes on Mar2021 with outcome of recovering , joints and muscle pain, headache on Mar2021 with outcome of recovering , chills on Mar2021 with outcome of recovering , night sweats on Mar2021 with outcome of recovering , nausea on 13Mar2021 14:30 with outcome of recovering , arm pain first day on 09Mar2021 with outcome of recovering , fatigue on Mar2021 with outcome of recovering.  The patient underwent lab tests and procedures which included blood pressure measurement: 120's-30's/70's, blood pressure measurement: 199/98   on 13Mar2021, platelet count: 99, sars-cov-2 test: Several negative tests on unspecified date.  The patient went to Urgent Care twice. The patient took no other vaccine in four weeks and the patient was not COVID tested post vaccination.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Night sweats, Pain in extremity, Palpitations, Platelet count, SARS-CoV-2 test
Clinical narrative: lightheaded; stomach pain; feeling like fainting; that happened parallel to erratic high blood pressure 199/98.; nausea; Arm pain first day.; fatigue; palpitations; shakes; joints and muscle pain; joints and muscle pain; headache; Chills; night sweats; This is a spontaneous report from a contactable consumer. A 60-years-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 09Mar2021 10:30 (Batch/Lot Number: EN6199) as SINGLE DOSE (at the age of 60 years) for covid-19 immunisation .  Medical history included immune thrombocytopenia from an unknown date and unknown if ongoing , hypertension from an unknown date and unknown if ongoing , drug hypersensitivity from an unknown date and unknown if ongoing , covid-19 from Mar2020 to Sep2020, (COVID 19 Long-Hauler from Mar-Sep2020). Concomitant medications included amlodipine besilate, benazepril hydrochloride (AMLODIPINE BENAZEPRIL); simvastatin (SIMVASTATIN).  The patient previously took aspirin [acetylsalicylic acid] and experienced anaphylactic reaction, zantac and experienced rash and experienced peripheral swelling.  The patient experienced feeling like fainting (medically significant) on 13Mar2021 14:30 with outcome of recovering , that happened parallel to erratic high blood pressure 199/98 on 13Mar2021 14:30 with outcome of recovering , palpitations  on Mar2021 with outcome of recovering , lightheaded on 13Mar2021 14:30 with outcome of recovering , stomach pain on 13Mar2021 14:30 with outcome of recovering , shakes on Mar2021 with outcome of recovering , joints and muscle pain, headache on Mar2021 with outcome of recovering , chills on Mar2021 with outcome of recovering , night sweats on Mar2021 with outcome of recovering , nausea on 13Mar2021 14:30 with outcome of recovering , arm pain first day on 09Mar2021 with outcome of recovering , fatigue on Mar2021 with outcome of recovering.  The patient underwent lab tests and procedures which included blood pressure measurement: 120's-30's/70's, blood pressure measurement: 199/98   on 13Mar2021, platelet count: 99, sars-cov-2 test: Several negative tests on unspecified date.  The patient went to Urgent Care twice. The patient took no other vaccine in four weeks and the patient was not COVID tested post vaccination.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Syncope, Tremor
Clinical narrative: lightheaded; stomach pain; feeling like fainting; that happened parallel to erratic high blood pressure 199/98.; nausea; Arm pain first day.; fatigue; palpitations; shakes; joints and muscle pain; joints and muscle pain; headache; Chills; night sweats; This is a spontaneous report from a contactable consumer. A 60-years-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 09Mar2021 10:30 (Batch/Lot Number: EN6199) as SINGLE DOSE (at the age of 60 years) for covid-19 immunisation .  Medical history included immune thrombocytopenia from an unknown date and unknown if ongoing , hypertension from an unknown date and unknown if ongoing , drug hypersensitivity from an unknown date and unknown if ongoing , covid-19 from Mar2020 to Sep2020, (COVID 19 Long-Hauler from Mar-Sep2020). Concomitant medications included amlodipine besilate, benazepril hydrochloride (AMLODIPINE BENAZEPRIL); simvastatin (SIMVASTATIN).  The patient previously took aspirin [acetylsalicylic acid] and experienced anaphylactic reaction, zantac and experienced rash and experienced peripheral swelling.  The patient experienced feeling like fainting (medically significant) on 13Mar2021 14:30 with outcome of recovering , that happened parallel to erratic high blood pressure 199/98 on 13Mar2021 14:30 with outcome of recovering , palpitations  on Mar2021 with outcome of recovering , lightheaded on 13Mar2021 14:30 with outcome of recovering , stomach pain on 13Mar2021 14:30 with outcome of recovering , shakes on Mar2021 with outcome of recovering , joints and muscle pain, headache on Mar2021 with outcome of recovering , chills on Mar2021 with outcome of recovering , night sweats on Mar2021 with outcome of recovering , nausea on 13Mar2021 14:30 with outcome of recovering , arm pain first day on 09Mar2021 with outcome of recovering , fatigue on Mar2021 with outcome of recovering.  The patient underwent lab tests and procedures which included blood pressure measurement: 120's-30's/70's, blood pressure measurement: 199/98   on 13Mar2021, platelet count: 99, sars-cov-2 test: Several negative tests on unspecified date.  The patient went to Urgent Care twice. The patient took no other vaccine in four weeks and the patient was not COVID tested post vaccination.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood creatine phosphokinase, Dystonia, Haematology test, Laboratory test
Clinical narrative: Dystonic reaction; Involuntary muscle movements and spasm; Involuntary muscle movements and spasm; This is a spontaneous report from a contactable consumer (patient).  A 39-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the left arm, on 23Mar2021 at 02:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. Concomitant medications, taken within two weeks of vaccination, included ethinylestradiol, norgestimate (MANUFACTURER UNKNOWN) taken for birth control. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced dystonic reaction and involuntary muscle movements and spasm on 23Mar2021 at 18:15. Therapeutic measures were taken as a result of the events, which included diphenhydramine (MANUFACTURER UNKNOWN) and lorazepam (MANUFACTURER UNKNOWN). The clinical outcome of dystonic reaction and involuntary muscle movements and spasm was recovered on an unspecified date. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyskinesia, Dystonia, Muscle spasms
Clinical narrative: Dystonic reaction; Involuntary muscle movements and spasm; Involuntary muscle movements and spasm; This is a spontaneous report from a contactable consumer (patient).  A 39-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the left arm, on 23Mar2021 at 02:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. Concomitant medications, taken within two weeks of vaccination, included ethinylestradiol, norgestimate (MANUFACTURER UNKNOWN) taken for birth control. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced dystonic reaction and involuntary muscle movements and spasm on 23Mar2021 at 18:15. Therapeutic measures were taken as a result of the events, which included diphenhydramine (MANUFACTURER UNKNOWN) and lorazepam (MANUFACTURER UNKNOWN). The clinical outcome of dystonic reaction and involuntary muscle movements and spasm was recovered on an unspecified date. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 74.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Chills, Feeling cold, Headache, Influenza virus test negative, Nausea
Clinical narrative: her blood pressure was very low the next morning; she felt really weak; nausea; she lost a lot of fluids/I was so dehydrated; hadn't eaten anything; stated she started salivating and then threw up; stated she threw up once; she had a severe headache; she was shivering all evening and she couldn't get warm; she had body aches; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3249, NDC number: Unknown, Expiration Date: May2021, Manufacturer: Unspecified) via an unspecified route of administration at right arm on 15Jan2021 at single dose for COVID-19 immunisation. Medical history of patient included knee pain and anxiety. Patient's concomitant medications included tramadol, paracetamol both 500 mg for knee pain and hydroxyzine hydrochloride (25mg tablet up to three times a day as needed by mouth, she does not take every day) for anxiety. On 15Jan2021 after vaccination patient experienced salivating and then threw up, stated she threw up once, severe headache, shivering all evening and she couldn't get warm, body aches, nausea, lost a lot of fluids/I was so dehydrated, hadn't eaten anything and her blood pressure was very low the next morning, she felt really weak on 16Jan2021. She required urgent care trip for IV fluids, "She was so dehydrated" and was "miserable" with her symptoms. She said she lost a lot of fluids and hadn't eaten anything. Patient wants to get the second COVID-19 vaccine dose because she is scheduled to have a knee replacement on 26Feb2021. She said she also had to deal with the pain in her knee, clarifying that is why she is getting a knee replacement. IV fluids (clarified as Saline), tylenol given as treatment. She reported when she got home she drank Pedialyte to try to rehydrate herself. She reported she went to urgent care on Saturday (16Jan2021), and by Monday 18Jan2021, she was feeling better, but she didn't golf on Tuesday, 19Jan2021. patient underwent lab tests and procedures which included blood pressure measurement which very low, influenza virus test and sars-cov-2 test was negative on 16Jan2021, blood test was fine. Patient said yes for investigation assessment. The outcome of event was recovered on 15Jan2021 for Increased salivation and Vomited and for all other event outcome was recovered on Jan2021.
Age: 74.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Pain, Pain in extremity, SARS-CoV-2 test negative, Vomiting
Clinical narrative: her blood pressure was very low the next morning; she felt really weak; nausea; she lost a lot of fluids/I was so dehydrated; hadn't eaten anything; stated she started salivating and then threw up; stated she threw up once; she had a severe headache; she was shivering all evening and she couldn't get warm; she had body aches; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3249, NDC number: Unknown, Expiration Date: May2021, Manufacturer: Unspecified) via an unspecified route of administration at right arm on 15Jan2021 at single dose for COVID-19 immunisation. Medical history of patient included knee pain and anxiety. Patient's concomitant medications included tramadol, paracetamol both 500 mg for knee pain and hydroxyzine hydrochloride (25mg tablet up to three times a day as needed by mouth, she does not take every day) for anxiety. On 15Jan2021 after vaccination patient experienced salivating and then threw up, stated she threw up once, severe headache, shivering all evening and she couldn't get warm, body aches, nausea, lost a lot of fluids/I was so dehydrated, hadn't eaten anything and her blood pressure was very low the next morning, she felt really weak on 16Jan2021. She required urgent care trip for IV fluids, "She was so dehydrated" and was "miserable" with her symptoms. She said she lost a lot of fluids and hadn't eaten anything. Patient wants to get the second COVID-19 vaccine dose because she is scheduled to have a knee replacement on 26Feb2021. She said she also had to deal with the pain in her knee, clarifying that is why she is getting a knee replacement. IV fluids (clarified as Saline), tylenol given as treatment. She reported when she got home she drank Pedialyte to try to rehydrate herself. She reported she went to urgent care on Saturday (16Jan2021), and by Monday 18Jan2021, she was feeling better, but she didn't golf on Tuesday, 19Jan2021. patient underwent lab tests and procedures which included blood pressure measurement which very low, influenza virus test and sars-cov-2 test was negative on 16Jan2021, blood test was fine. Patient said yes for investigation assessment. The outcome of event was recovered on 15Jan2021 for Increased salivation and Vomited and for all other event outcome was recovered on Jan2021.
Age: 74.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Asthenia, Blood pressure measurement, Blood test, Chills, Dehydration
Clinical narrative: her blood pressure was very low the next morning; she felt really weak; nausea; she lost a lot of fluids/I was so dehydrated; hadn't eaten anything; stated she started salivating and then threw up; stated she threw up once; she had a severe headache; she was shivering all evening and she couldn't get warm; she had body aches; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3249, NDC number: Unknown, Expiration Date: May2021, Manufacturer: Unspecified) via an unspecified route of administration at right arm on 15Jan2021 at single dose for COVID-19 immunisation. Medical history of patient included knee pain and anxiety. Patient's concomitant medications included tramadol, paracetamol both 500 mg for knee pain and hydroxyzine hydrochloride (25mg tablet up to three times a day as needed by mouth, she does not take every day) for anxiety. On 15Jan2021 after vaccination patient experienced salivating and then threw up, stated she threw up once, severe headache, shivering all evening and she couldn't get warm, body aches, nausea, lost a lot of fluids/I was so dehydrated, hadn't eaten anything and her blood pressure was very low the next morning, she felt really weak on 16Jan2021. She required urgent care trip for IV fluids, "She was so dehydrated" and was "miserable" with her symptoms. She said she lost a lot of fluids and hadn't eaten anything. Patient wants to get the second COVID-19 vaccine dose because she is scheduled to have a knee replacement on 26Feb2021. She said she also had to deal with the pain in her knee, clarifying that is why she is getting a knee replacement. IV fluids (clarified as Saline), tylenol given as treatment. She reported when she got home she drank Pedialyte to try to rehydrate herself. She reported she went to urgent care on Saturday (16Jan2021), and by Monday 18Jan2021, she was feeling better, but she didn't golf on Tuesday, 19Jan2021. patient underwent lab tests and procedures which included blood pressure measurement which very low, influenza virus test and sars-cov-2 test was negative on 16Jan2021, blood test was fine. Patient said yes for investigation assessment. The outcome of event was recovered on 15Jan2021 for Increased salivation and Vomited and for all other event outcome was recovered on Jan2021.
Age: 74.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Eating disorder, Headache, Hypotension, Influenza virus test, Nausea
Clinical narrative: her blood pressure was very low the next morning; she felt really weak; nausea; she lost a lot of fluids/I was so dehydrated; hadn't eaten anything; stated she started salivating and then threw up; stated she threw up once; she had a severe headache; she was shivering all evening and she couldn't get warm; she had body aches; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3249, NDC number: Unknown, Expiration Date: May2021, Manufacturer: Unspecified) via an unspecified route of administration at right arm on 15Jan2021 at single dose for COVID-19 immunisation. Medical history of patient included knee pain and anxiety. Patient's concomitant medications included tramadol, paracetamol both 500 mg for knee pain and hydroxyzine hydrochloride (25mg tablet up to three times a day as needed by mouth, she does not take every day) for anxiety. On 15Jan2021 after vaccination patient experienced salivating and then threw up, stated she threw up once, severe headache, shivering all evening and she couldn't get warm, body aches, nausea, lost a lot of fluids/I was so dehydrated, hadn't eaten anything and her blood pressure was very low the next morning, she felt really weak on 16Jan2021. She required urgent care trip for IV fluids, "She was so dehydrated" and was "miserable" with her symptoms. She said she lost a lot of fluids and hadn't eaten anything. Patient wants to get the second COVID-19 vaccine dose because she is scheduled to have a knee replacement on 26Feb2021. She said she also had to deal with the pain in her knee, clarifying that is why she is getting a knee replacement. IV fluids (clarified as Saline), tylenol given as treatment. She reported when she got home she drank Pedialyte to try to rehydrate herself. She reported she went to urgent care on Saturday (16Jan2021), and by Monday 18Jan2021, she was feeling better, but she didn't golf on Tuesday, 19Jan2021. patient underwent lab tests and procedures which included blood pressure measurement which very low, influenza virus test and sars-cov-2 test was negative on 16Jan2021, blood test was fine. Patient said yes for investigation assessment. The outcome of event was recovered on 15Jan2021 for Increased salivation and Vomited and for all other event outcome was recovered on Jan2021.
Age: 74.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Pain, SARS-CoV-2 test, Salivary hypersecretion, Vomiting
Clinical narrative: her blood pressure was very low the next morning; she felt really weak; nausea; she lost a lot of fluids/I was so dehydrated; hadn't eaten anything; stated she started salivating and then threw up; stated she threw up once; she had a severe headache; she was shivering all evening and she couldn't get warm; she had body aches; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3249, NDC number: Unknown, Expiration Date: May2021, Manufacturer: Unspecified) via an unspecified route of administration at right arm on 15Jan2021 at single dose for COVID-19 immunisation. Medical history of patient included knee pain and anxiety. Patient's concomitant medications included tramadol, paracetamol both 500 mg for knee pain and hydroxyzine hydrochloride (25mg tablet up to three times a day as needed by mouth, she does not take every day) for anxiety. On 15Jan2021 after vaccination patient experienced salivating and then threw up, stated she threw up once, severe headache, shivering all evening and she couldn't get warm, body aches, nausea, lost a lot of fluids/I was so dehydrated, hadn't eaten anything and her blood pressure was very low the next morning, she felt really weak on 16Jan2021. She required urgent care trip for IV fluids, "She was so dehydrated" and was "miserable" with her symptoms. She said she lost a lot of fluids and hadn't eaten anything. Patient wants to get the second COVID-19 vaccine dose because she is scheduled to have a knee replacement on 26Feb2021. She said she also had to deal with the pain in her knee, clarifying that is why she is getting a knee replacement. IV fluids (clarified as Saline), tylenol given as treatment. She reported when she got home she drank Pedialyte to try to rehydrate herself. She reported she went to urgent care on Saturday (16Jan2021), and by Monday 18Jan2021, she was feeling better, but she didn't golf on Tuesday, 19Jan2021. patient underwent lab tests and procedures which included blood pressure measurement which very low, influenza virus test and sars-cov-2 test was negative on 16Jan2021, blood test was fine. Patient said yes for investigation assessment. The outcome of event was recovered on 15Jan2021 for Increased salivation and Vomited and for all other event outcome was recovered on Jan2021.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Diarrhoea, Disorientation, Malaise, Vomiting
Clinical narrative: 3/24/2021 Pt. went to ER with nausea/vomiting and passed out - approx 24 hrs after vaccine and diarrhea.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Loss of consciousness, Nausea, Vomiting
Clinical narrative: 3/24/2021 Pt. went to ER with nausea/vomiting and passed out - approx 24 hrs after vaccine and diarrhea.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray abnormal, Dyspnoea, Lung disorder, SARS-CoV-2 test negative
Clinical narrative: Wound up with shortness of breath; Oxygen levels dropped below standard; Chest X-ray showed signs of Covid like characteristics; Chest X-ray showed signs of Covid like characteristics; This is a spontaneous report from a contactable consumer. A 83-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration at the age of 83-years, administered in arm left on 03Mar2021 13:00 as single dose for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Wound up with shortness of breath and taken to hospital on 18Mar2021 0:00. Chest X-ray showed signs of Covid like characteristics. Oxygen levels dropped below standard. This was 2 weeks after the first dose. Ae resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, hospitalization. No days hospitalization: 3. Treatment included Oxygen, chest X-rays, medicine was received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. Covid test post vaccination via Nasal Swab with Hospital Administered on 23Mar2021, Covid test result was Negative; Covid test post vaccination via Nasal Swab on 24Mar2021, Covid test result was Negative. There is no known allergies to medications, food, or other products. Other medical history was known by hospital. The outcome of the events was resolving.  Information on the lot/batch number has been requested.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Drug ineffective, Dyspnoea, Oxygen saturation, Oxygen saturation decreased
Clinical narrative: Wound up with shortness of breath; Oxygen levels dropped below standard; Chest X-ray showed signs of Covid like characteristics; Chest X-ray showed signs of Covid like characteristics; This is a spontaneous report from a contactable consumer. A 83-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration at the age of 83-years, administered in arm left on 03Mar2021 13:00 as single dose for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Wound up with shortness of breath and taken to hospital on 18Mar2021 0:00. Chest X-ray showed signs of Covid like characteristics. Oxygen levels dropped below standard. This was 2 weeks after the first dose. Ae resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, hospitalization. No days hospitalization: 3. Treatment included Oxygen, chest X-rays, medicine was received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. Covid test post vaccination via Nasal Swab with Hospital Administered on 23Mar2021, Covid test result was Negative; Covid test post vaccination via Nasal Swab on 24Mar2021, Covid test result was Negative. There is no known allergies to medications, food, or other products. Other medical history was known by hospital. The outcome of the events was resolving.  Information on the lot/batch number has been requested.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test, Suspected COVID-19
Clinical narrative: Wound up with shortness of breath; Oxygen levels dropped below standard; Chest X-ray showed signs of Covid like characteristics; Chest X-ray showed signs of Covid like characteristics; This is a spontaneous report from a contactable consumer. A 83-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration at the age of 83-years, administered in arm left on 03Mar2021 13:00 as single dose for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Wound up with shortness of breath and taken to hospital on 18Mar2021 0:00. Chest X-ray showed signs of Covid like characteristics. Oxygen levels dropped below standard. This was 2 weeks after the first dose. Ae resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, hospitalization. No days hospitalization: 3. Treatment included Oxygen, chest X-rays, medicine was received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. Covid test post vaccination via Nasal Swab with Hospital Administered on 23Mar2021, Covid test result was Negative; Covid test post vaccination via Nasal Swab on 24Mar2021, Covid test result was Negative. There is no known allergies to medications, food, or other products. Other medical history was known by hospital. The outcome of the events was resolving.  Information on the lot/batch number has been requested.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Antinuclear antibody negative, Feeling hot, Flushing, Full blood count normal, Heart rate increased
Clinical narrative: Pt approached staff and stated she felt flushed; pt has hives on chest; pt has a history of hives from an undiagnosed allergy so she took 50mg of her own Benadryl; BP and pulse were elevated most likely due to anxiety; pt went into office with Medic and EMT to rest and be observed longer.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypertension, Thyroid function test normal, Urticaria, Vision blurred
Clinical narrative: Pt approached staff and stated she felt flushed; pt has hives on chest; pt has a history of hives from an undiagnosed allergy so she took 50mg of her own Benadryl; BP and pulse were elevated most likely due to anxiety; pt went into office with Medic and EMT to rest and be observed longer.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Flushing, Heart rate increased, Urticaria
Clinical narrative: Pt approached staff and stated she felt flushed; pt has hives on chest; pt has a history of hives from an undiagnosed allergy so she took 50mg of her own Benadryl; BP and pulse were elevated most likely due to anxiety; pt went into office with Medic and EMT to rest and be observed longer.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Erythema, Headache, Lethargy
Clinical narrative: 1. Local reaction to immunization, initial encounter Reassurance offered.  Suggested use of OTC antihistamines for itching and swelling if it should recur following her second immunization.  Discussed that this is common and it is safe to complete immunization series.     Subjective:   38 y.o. female presents 10 days following first dose Covid immunization in her left deltoid.  She noticed a firm lump at the immunization site several days afterwards which has spread out and become a more diffuse swelling of the deltoid.  This is been associated with some itching over the overlying skin but no rash or systemic symptoms.  She thinks she may have noticed a single red hive on the bridge of her nose that has since resolved.  She has been using topical Benadryl on the arm. The patient's past medical, family and social history was reviewed and updated in EPIC.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle twitching, Neck pain, Pain, Pruritus, Sensory disturbance
Clinical narrative: 1. Local reaction to immunization, initial encounter Reassurance offered.  Suggested use of OTC antihistamines for itching and swelling if it should recur following her second immunization.  Discussed that this is common and it is safe to complete immunization series.     Subjective:   38 y.o. female presents 10 days following first dose Covid immunization in her left deltoid.  She noticed a firm lump at the immunization site several days afterwards which has spread out and become a more diffuse swelling of the deltoid.  This is been associated with some itching over the overlying skin but no rash or systemic symptoms.  She thinks she may have noticed a single red hive on the bridge of her nose that has since resolved.  She has been using topical Benadryl on the arm. The patient's past medical, family and social history was reviewed and updated in EPIC.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling, Urticaria
Clinical narrative: 1. Local reaction to immunization, initial encounter Reassurance offered.  Suggested use of OTC antihistamines for itching and swelling if it should recur following her second immunization.  Discussed that this is common and it is safe to complete immunization series.     Subjective:   38 y.o. female presents 10 days following first dose Covid immunization in her left deltoid.  She noticed a firm lump at the immunization site several days afterwards which has spread out and become a more diffuse swelling of the deltoid.  This is been associated with some itching over the overlying skin but no rash or systemic symptoms.  She thinks she may have noticed a single red hive on the bridge of her nose that has since resolved.  She has been using topical Benadryl on the arm. The patient's past medical, family and social history was reviewed and updated in EPIC.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site induration, Injection site mass, Local reaction, Pruritus, Swelling
Clinical narrative: 1. Local reaction to immunization, initial encounter Reassurance offered.  Suggested use of OTC antihistamines for itching and swelling if it should recur following her second immunization.  Discussed that this is common and it is safe to complete immunization series.     Subjective:   38 y.o. female presents 10 days following first dose Covid immunization in her left deltoid.  She noticed a firm lump at the immunization site several days afterwards which has spread out and become a more diffuse swelling of the deltoid.  This is been associated with some itching over the overlying skin but no rash or systemic symptoms.  She thinks she may have noticed a single red hive on the bridge of her nose that has since resolved.  She has been using topical Benadryl on the arm. The patient's past medical, family and social history was reviewed and updated in EPIC.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: 1. Local reaction to immunization, initial encounter Reassurance offered.  Suggested use of OTC antihistamines for itching and swelling if it should recur following her second immunization.  Discussed that this is common and it is safe to complete immunization series.     Subjective:   38 y.o. female presents 10 days following first dose Covid immunization in her left deltoid.  She noticed a firm lump at the immunization site several days afterwards which has spread out and become a more diffuse swelling of the deltoid.  This is been associated with some itching over the overlying skin but no rash or systemic symptoms.  She thinks she may have noticed a single red hive on the bridge of her nose that has since resolved.  She has been using topical Benadryl on the arm. The patient's past medical, family and social history was reviewed and updated in EPIC.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary normal, Blood potassium decreased, Blood test abnormal, Chest X-ray normal, Chest discomfort
Clinical narrative: Neuropathy; Shortness of breath; chest tightness; ringing in ears; fatigue; brain fog; dizziness; vomiting; vision changes; This is a spontaneous report from a contactable consumer. A 73-years-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Lot Number: EN6205), via an unspecified route of administration, administered in Arm Right on 09Mar2021 15:00 as SINGLE DOSE for covid-19 immunisation. Medical history included asthma, glaucoma, Manages cholesterol, controlled high BP and iodine contrast. The patient's concomitant medications were not reported. The patient experienced neuropathy, shortness of breath, chest tightness , ringing in ears, fatigue, brain fog, dizziness, vomiting and vision changes on 10Mar2021 03:00.  The patient was hospitalized for all of the events for 2 days on an unspecified date. The patient underwent lab tests and procedures which included Nasal Swab: negative on 13Mar2021. The patient was not pregnant. Outcome of the events was not recovered.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Dizziness, Dyspnoea, Electrocardiogram normal, Fatigue
Clinical narrative: Neuropathy; Shortness of breath; chest tightness; ringing in ears; fatigue; brain fog; dizziness; vomiting; vision changes; This is a spontaneous report from a contactable consumer. A 73-years-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Lot Number: EN6205), via an unspecified route of administration, administered in Arm Right on 09Mar2021 15:00 as SINGLE DOSE for covid-19 immunisation. Medical history included asthma, glaucoma, Manages cholesterol, controlled high BP and iodine contrast. The patient's concomitant medications were not reported. The patient experienced neuropathy, shortness of breath, chest tightness , ringing in ears, fatigue, brain fog, dizziness, vomiting and vision changes on 10Mar2021 03:00.  The patient was hospitalized for all of the events for 2 days on an unspecified date. The patient underwent lab tests and procedures which included Nasal Swab: negative on 13Mar2021. The patient was not pregnant. Outcome of the events was not recovered.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Head lag, Loss of consciousness, Mononeuropathy, Neuropathy peripheral, Sleep disorder
Clinical narrative: Neuropathy; Shortness of breath; chest tightness; ringing in ears; fatigue; brain fog; dizziness; vomiting; vision changes; This is a spontaneous report from a contactable consumer. A 73-years-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Lot Number: EN6205), via an unspecified route of administration, administered in Arm Right on 09Mar2021 15:00 as SINGLE DOSE for covid-19 immunisation. Medical history included asthma, glaucoma, Manages cholesterol, controlled high BP and iodine contrast. The patient's concomitant medications were not reported. The patient experienced neuropathy, shortness of breath, chest tightness , ringing in ears, fatigue, brain fog, dizziness, vomiting and vision changes on 10Mar2021 03:00.  The patient was hospitalized for all of the events for 2 days on an unspecified date. The patient underwent lab tests and procedures which included Nasal Swab: negative on 13Mar2021. The patient was not pregnant. Outcome of the events was not recovered.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus, Vision blurred, Vomiting
Clinical narrative: Neuropathy; Shortness of breath; chest tightness; ringing in ears; fatigue; brain fog; dizziness; vomiting; vision changes; This is a spontaneous report from a contactable consumer. A 73-years-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Lot Number: EN6205), via an unspecified route of administration, administered in Arm Right on 09Mar2021 15:00 as SINGLE DOSE for covid-19 immunisation. Medical history included asthma, glaucoma, Manages cholesterol, controlled high BP and iodine contrast. The patient's concomitant medications were not reported. The patient experienced neuropathy, shortness of breath, chest tightness , ringing in ears, fatigue, brain fog, dizziness, vomiting and vision changes on 10Mar2021 03:00.  The patient was hospitalized for all of the events for 2 days on an unspecified date. The patient underwent lab tests and procedures which included Nasal Swab: negative on 13Mar2021. The patient was not pregnant. Outcome of the events was not recovered.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dizziness, Dyspnoea, Fatigue, Feeling abnormal
Clinical narrative: Neuropathy; Shortness of breath; chest tightness; ringing in ears; fatigue; brain fog; dizziness; vomiting; vision changes; This is a spontaneous report from a contactable consumer. A 73-years-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Lot Number: EN6205), via an unspecified route of administration, administered in Arm Right on 09Mar2021 15:00 as SINGLE DOSE for covid-19 immunisation. Medical history included asthma, glaucoma, Manages cholesterol, controlled high BP and iodine contrast. The patient's concomitant medications were not reported. The patient experienced neuropathy, shortness of breath, chest tightness , ringing in ears, fatigue, brain fog, dizziness, vomiting and vision changes on 10Mar2021 03:00.  The patient was hospitalized for all of the events for 2 days on an unspecified date. The patient underwent lab tests and procedures which included Nasal Swab: negative on 13Mar2021. The patient was not pregnant. Outcome of the events was not recovered.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neuropathy peripheral, SARS-CoV-2 test, Tinnitus, Visual impairment, Vomiting
Clinical narrative: Neuropathy; Shortness of breath; chest tightness; ringing in ears; fatigue; brain fog; dizziness; vomiting; vision changes; This is a spontaneous report from a contactable consumer. A 73-years-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Lot Number: EN6205), via an unspecified route of administration, administered in Arm Right on 09Mar2021 15:00 as SINGLE DOSE for covid-19 immunisation. Medical history included asthma, glaucoma, Manages cholesterol, controlled high BP and iodine contrast. The patient's concomitant medications were not reported. The patient experienced neuropathy, shortness of breath, chest tightness , ringing in ears, fatigue, brain fog, dizziness, vomiting and vision changes on 10Mar2021 03:00.  The patient was hospitalized for all of the events for 2 days on an unspecified date. The patient underwent lab tests and procedures which included Nasal Swab: negative on 13Mar2021. The patient was not pregnant. Outcome of the events was not recovered.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anal incontinence, Chills, Constipation, Cough, Fatigue
Clinical narrative: This is a spontaneous report from a contactable consumer (patient).   A 59-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history included had the COVID-19 Virus in Mar2020, and it took her to May2020 to feel better, C-Diff in 2016 was caused by antibiotics that killed off her good bacteria in her intestines. She said she then had to take a very expensive antibiotic for months to treat her C-Diff. She said nothing helped, so she did her own research, and got a fecal implant.  The patient's concomitant medications were not reported.  The patient said the COVID-19 Vaccine was giving her C-Diff symptoms, and she was losing intestinal lining along with having fecal matter mixed in. She said she can't control her bowels. She said if she eats something, it goes completely through her system and out the other end. She said her symptoms started Saturday (20Mar2021), where she noticed she was shedding her intestinal lining, and by Sunday (21Mar2021) she was oozing fecal matter, it is getting worse. She reported her symptoms were very nasty. The events outcome was not recovered. Information on batch / Lot number has been requested.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anal incontinence, Clostridium difficile infection, Functional gastrointestinal disorder
Clinical narrative: This is a spontaneous report from a contactable consumer (patient).   A 59-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history included had the COVID-19 Virus in Mar2020, and it took her to May2020 to feel better, C-Diff in 2016 was caused by antibiotics that killed off her good bacteria in her intestines. She said she then had to take a very expensive antibiotic for months to treat her C-Diff. She said nothing helped, so she did her own research, and got a fecal implant.  The patient's concomitant medications were not reported.  The patient said the COVID-19 Vaccine was giving her C-Diff symptoms, and she was losing intestinal lining along with having fecal matter mixed in. She said she can't control her bowels. She said if she eats something, it goes completely through her system and out the other end. She said her symptoms started Saturday (20Mar2021), where she noticed she was shedding her intestinal lining, and by Sunday (21Mar2021) she was oozing fecal matter, it is getting worse. She reported her symptoms were very nasty. The events outcome was not recovered. Information on batch / Lot number has been requested.